This is promising:
Cannabidiol slashes seizures in kids with rare epilepsy, study finds
Among children taking cannabidiol, the decrease in the frequency of convulsive seizures — which involve a loss of consciousness, stiffened muscles and jerking movements — was 23 percentage points greater than the decrease in seizures among children taking a placebo. The study was a randomized, double-blind, placebo-controlled human trial.
They were looking specifically at children with Dravet Syndrome, which is described as “a severe childhood-onset epilepsy that causes multiple kinds of seizures, developmental delays, speech and language problems, behavioral issues and movement and balance problems.” Sounds pretty awful. If nearly a quarter of those children respond well to cannabidiol, wow. Especially since other treatments are apparently not super useful for this syndrome.
1 thought on “Good News Tuesday”
CBD has been in the news for a while now, and not just in offbeat places like the Seattle free weekly papers, where I saw it first. For whatever reason, DOJ/DEA is working at utter cross purposes to NIH on this. CBD cannot get you high, by all accounts. Here’s some relevant testimony to Congress last year. Getting good drug studies is hard for schedule I drugs.